23rd Jul 2012 07:00
Directors' DealingsDirectors Receive Shares in Lieu of Fees
London and New York, 23 July 2012- Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 365,129 ordinary shares, representing 0.27% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the first and second quarters of 2012, priced at 3.924p, being the average of the closing mid-market price for the five days leading up to the market close on 19 July 2012.Following this issue, the directors' shareholdings in the Company are as follows:
Director | Number of New Shares | Total Shareholding | Percentage of voting rights |
R. James Macaleer | 265,129 | 23,802,862 | 17.58% |
Gerard Moufflet | 100,000 | 650,000 | 0.48% |
Director, Anthony Henfrey waived his fees for the first and second quarters of 2012.
Admission of the 365,129 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 30 July 2012. Following this allotment the total issued share capital of the Company will increase to 135,374,167 ordinary shares with each share holding one voting right.
For further information please contact:
Amphion Innovations
Charlie Morgan:
+1 212 210 6224
Seymour Pierce Limited
Freddy Crossley/ Mark Percy
+44 020 7107 8300
Cardew Group
Tim Robertson
+44 020 7930 0777
Related Shares:
AMP.L